Product Information
OLMESARTAN MEDOXOMIL 5 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.0575 per EA under NDC 62135088030. Its NADAC has been published 114 times since Jul 31, 2024.
FDA first approved this application on Feb 22, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Olmesartan Medoxomil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135088030
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA211049FDA Approved
2/22/2019
TE Code
AB
On Market Since
3/5/2019
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has been published 114 times since Jul 31, 2024, and over the history we have for it it has declined 21.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0575 per EA |
|---|---|
| All-time high | $0.0844 (Sep 11, 2024) |
| All-time low | $0.0551 (Aug 19, 2026) |
| 52-week high | $0.0593 |
| 52-week low | $0.0551 |
| Median price | $0.0593 |
| Average price | $0.0632 |
| Largest weekly change | -24.8% (Nov 20, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olmesartan Medoxomil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 5 MG TAB, manufactured by Chartwell RX LLC, is $0.0575 per EA (NDC 62135088030), effective Sep 30, 2026.
How has the price of OLMESARTAN MEDOXOMIL 5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has declined 21.5%. It has been tracked across 114 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 5 MG TAB?
Since Jul 31, 2024, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has ranged from a low of $0.0551 (Aug 19, 2026) to a high of $0.0844 (Sep 11, 2024), with a median of $0.0593 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 5 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN MEDOXOMIL 5 MG TAB?
OLMESARTAN MEDOXOMIL 5 MG TAB (NDC 62135088030) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.